156 related articles for article (PubMed ID: 33094334)
1. In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis.
Oyardi Ö; Savage PB; Erturan Z; Bozkurt-Guzel C
J Antimicrob Chemother; 2021 Jan; 76(2):443-450. PubMed ID: 33094334
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ceragenins against Burkholderia cepacia complex.
Demir ES; Oyardi O; Savage PB; Altay HO; Bozkurt-Guzel C
J Antibiot (Tokyo); 2022 Jul; 75(7):403-409. PubMed ID: 35562592
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen
Paprocka P; Mańkowska A; Skłodowski K; Król G; Wollny T; Lesiak A; Głuszek K; Savage PB; Durnaś B; Bucki R
Pathogens; 2022 May; 11(6):. PubMed ID: 35745475
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial and Antifungal Activities of Poloxamer Micelles Containing Ceragenin CSA-131 on Ciliated Tissues.
Hashemi MM; Holden BS; Taylor MF; Wilson J; Coburn J; Hilton B; Nance T; Gubler S; Genberg C; Deng S; Savage PB
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518893
[TBL] [Abstract][Full Text] [Related]
5. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
Pompilio A; Crocetta V; Confalone P; Nicoletti M; Petrucca A; Guarnieri S; Fiscarelli E; Savini V; Piccolomini R; Di Bonaventura G
BMC Microbiol; 2010 Apr; 10():102. PubMed ID: 20374629
[TBL] [Abstract][Full Text] [Related]
6. Comparative In Vitro Activities of First and Second-Generation Ceragenins Alone and in Combination with Antibiotics Against Multidrug-Resistant
Ozbek-Celik B; Damar-Celik D; Mataraci-Kara E; Bozkurt-Guzel C; Savage PB
Antibiotics (Basel); 2019 Aug; 8(3):. PubMed ID: 31461867
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial and Antibiofilm Activities of Ceragenins against
Bozkurt Güzel Ç; Hacioğlu M; Inci G; Savage PB
Turk J Pharm Sci; 2019 Dec; 16(4):444-449. PubMed ID: 32454748
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.
Pollini S; Di Pilato V; Landini G; Di Maggio T; Cannatelli A; Sottotetti S; Cariani L; Aliberti S; Blasi F; Sergio F; Rossolini GM; Pallecchi L
PLoS One; 2018; 13(10):e0203941. PubMed ID: 30273348
[TBL] [Abstract][Full Text] [Related]
9. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526
[TBL] [Abstract][Full Text] [Related]
10. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
Biočanin M; Madi H; Vasiljević Z; Kojić M; Jovčić B; Lozo J
Pol J Microbiol; 2017 Dec; 66(4):433-438. PubMed ID: 29319523
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.
Pompilio A; Crocetta V; Verginelli F; Di Bonaventura G
FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27242375
[TBL] [Abstract][Full Text] [Related]
12. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
Wu K; Yau YC; Matukas L; Waters V
Antimicrob Agents Chemother; 2013 Mar; 57(3):1546-8. PubMed ID: 23295930
[TBL] [Abstract][Full Text] [Related]
13. Potential of ceragenin CSA-13 and its mixture with pluronic F-127 as treatment of topical bacterial infections.
Leszczyńska K; Namiot A; Cruz K; Byfield FJ; Won E; Mendez G; Sokołowski W; Savage PB; Bucki R; Janmey PA
J Appl Microbiol; 2011 Jan; 110(1):229-38. PubMed ID: 20961363
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Activity of Ceragenins Against Carbapenem-Resistant Acinetobacter baumannii Strains in Both Checkerboard and Dynamic Time-Kill Assays.
Bozkurt-Guzel C; Inci G; Oyardi O; Savage PB
Curr Microbiol; 2020 Aug; 77(8):1419-1428. PubMed ID: 32189050
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of antimicrobial peptides and ceragenins against Legionella pneumophila.
Birteksoz-Tan AS; Zeybek Z; Hacioglu M; Savage PB; Bozkurt-Guzel C
J Antibiot (Tokyo); 2019 May; 72(5):291-297. PubMed ID: 30755738
[TBL] [Abstract][Full Text] [Related]
16. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
[TBL] [Abstract][Full Text] [Related]
17. Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
Hashemi MM; Rovig J; Holden BS; Taylor MF; Weber S; Wilson J; Hilton B; Zaugg AL; Ellis SW; Yost CD; Finnegan PM; Kistler CK; Berkow EL; Deng S; Lockhart SR; Peterson M; Savage PB
J Antimicrob Chemother; 2018 Jun; 73(6):1537-1545. PubMed ID: 29635279
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Multidrug-Resistant Bacteria, Isolated from Water and Plants in Nigeria, to Ceragenins.
Hashemi MM; Mmuoegbulam AO; Holden BS; Coburn J; Wilson J; Taylor MF; Reiley J; Baradaran D; Stenquist T; Deng S; Savage PB
Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30563216
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial and Antibiofilm Activities of Ceragenins Alone and in Combination with Levofloxacin Against Multidrug Resistant Myroides spp. Clinical Isolates from Patients with Urinary Tract Infections.
Oyardi O; Eltimur T; Demir ES; Alkan B; Savage PB; Akcali A; Bozkurt-Guzel C
Curr Microbiol; 2023 May; 80(6):210. PubMed ID: 37191731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
